Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Eoganachton Aug 13, 2024 11:31am
233 Views
Post# 36176595

RE:RE:RE:RE:SO IM MISSING THE GOOD NEWS

RE:RE:RE:RE:SO IM MISSING THE GOOD NEWSIf I'm reading it right, the swimmer's plot shows 6 CR's at 2 years. 1 of the 6 recurred at  27 months. But then there are another 10 or so patients who have hit (or almost hit) 2 years or more that Theralase has not yet received the 2 year data for. Plus there's 1 patient who was CR at 1.5 years who hasn't reached the 2 year evaluation yet. If all 16 are CR at 2 years that will show that 39% of patients who had a CR were still CR at 2 years. We can probably expect a CR rate a little lower than that but maybe not much.

riverrrow wrote: Thank you and everyone for your posts.  I didn't look at the Swimmer's plot until now.  I count 9 patients CR at 2 years (which is 720 days).  I'm sure those patients are pretty happy about that.  I was hoping the news release was going to say this; 9 patients CR at 2 years.  Not everyone is a statistician and is going to study charts and graphs to gleam out the good news.  GLTA.


<< Previous
Bullboard Posts
Next >>